Background Lung cancer stands as the second most prevalent malignant neoplasm
worldwide. Addressing the underlying mechanisms propelling the progression of non-small …

Alternative splicing (AS) and the regulation of AS by splicing factors play critical roles in
cancer. Plant homeodomain (PHD)–finger domain protein PHF5A, a critical splicing factor …

Background PHD-finger domain protein 5A (PHF5A) is a highly conserved small
transcriptional regulator also involved in pre-mRNA splicing; however, its biological …

Objective. Cancer stem-like cells (CSLCs) are closely associated with tumor recurrence,
metastasis, and drug-resistance. PHD-finger domain protein 5A (PHF5A) is related to …

Objectives Four and a half LIM domain 2 protein (FHL2) was reported to regulate the
progression of various cancers and this study aimed to clarify the intrinsic mechanism of …

Background There have been many significant advances in the diagnosis and treatment of
non-small cell lung cancer (NSCLC). However, the mechanism underlying the progression …

Background Aberrantly expressed PCDH7 participates in the malignant progression of many
cancers. PCDH7 has been newly discovered as a risk factor in lung cancer, but its functional …

Objective Cancer is a predominant cause of death globally. PHD-finger domain protein 5 A
(PHF5A) has been reported to participate in various cancers; however, there has been no …

To improve the poor survival rate of lung cancer patients, we investigated the role of HDGF‐
related protein 3 (HRP‐3) as a potential biomarker for lung cancer. The expression of …

Background Antiangiogenetic therapy is one of the effective strategies for non-small cell
lung cancer (NSCLC) treatment. Four-and-a-half LIM-domain protein 2 (FHL2) serves as a …